tiprankstipranks
Trending News
More News >
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD
US Market

Tvardi Therapeutics (TVRD) Technical Analysis

Compare
2,286 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Tvardi Therapeutics’s (TVRD) Moving Averages Convergence Divergence (MACD) indicator is 2.97, suggesting Tvardi Therapeutics is a Sell.
Tvardi Therapeutics’s (TVRD) 20-Day exponential moving average is 25.94, while Tvardi Therapeutics’s (TVRD) share price is $32.88, making it a Buy.
Tvardi Therapeutics’s (TVRD) 50-Day exponential moving average is 21.71, while Tvardi Therapeutics’s (TVRD) share price is $32.88, making it a Buy.

Tvardi Therapeutics (TVRD) Pivot Points

May 24, 2025, 03:15 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
22.56
24.97
28.84
31.25
35.13
37.54
41.41
Fibonacci
24.97
27.37
28.85
31.25
33.65
35.14
37.54
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Tvardi Therapeutics (TVRD) Moving Averages

May 24, 2025, 03:15 AM
Period
Simple
Exponential
MA5
28.95Buy
30.06Buy
MA10
27.61Buy
28.30Buy
MA20
26.11Buy
25.94Buy
MA50
20.03Buy
21.71Buy
MA100
17.46Buy
18.62Buy
MA200
14.23Buy
15.95Buy
Tvardi Therapeutics’s (TVRD) 10-Day exponential moving average is 28.30, while Tvardi Therapeutics’s (TVRD) share price is $32.88, making it a Buy.
Tvardi Therapeutics’s (TVRD) 100-Day exponential moving average is 18.62, while Tvardi Therapeutics’s (TVRD) share price is $32.88, making it a Buy.
Tvardi Therapeutics’s (TVRD) stock price is $32.88 and Tvardi Therapeutics’s (TVRD) 50-day simple moving average is 20.03, creating a Buy signal.
Tvardi Therapeutics’s (TVRD) stock price is $32.88 and Tvardi Therapeutics’s (TVRD) 100-day simple moving average is 17.46, creating a Buy signal.
Tvardi Therapeutics’s (TVRD) stock price is $32.88 and Tvardi Therapeutics’s (TVRD) 200-day simple moving average is 14.23, creating a Buy signal.

Tvardi Therapeutics (TVRD) Technical Indicators

May 24, 2025, 03:15 AM
Name
Value
Implied Action
RSI (14)
78.89
Sell
STOCH (9,6)
86.88
Sell
STOCHRSI (14)
87.51
Sell
MACD (12,26)
2.97
Sell
ADX (14)
46.99
Neutral
Williams %R
-13.00
Sell
CCI (14)
250.94
Sell
ATR (14)
2.58
-
Ultimate Oscillator
57.03
Neutral
ROC
23.01
Buy
Tvardi Therapeutics’s (TVRD) Relative Strength Index (RSI) is 78.89, creating a Sell signal.
Tvardi Therapeutics’s (TVRD) Trend Strength Indicator (ADX) is 46.99, creating a Neutral signal.
Tvardi Therapeutics’s (TVRD) Commodity Channel Index (CCI) is 250.94, creating a Sell signal.
Tvardi Therapeutics’s (TVRD) Price Rate of Change (ROC) is 23.01, creating a Buy signal.

FAQ

Is TVRD a Buy, Hold, or Sell?
Based on TVRD’s technical indicators, TVRD is a Buy.
    What is TVRD’s RSI (14)?
    TVRD’s RSI (14) is 78.89, which suggests TVRD is a Sell.
      What is TVRD’s MACD?
      TVRD’s MACD is 2.97, which suggests TVRD is a Sell.
        What is TVRD’s 5-day moving average?
        TVRD’s 5-day moving average is 28.95, which suggests TVRD is a Buy.
          What is TVRD’s 20-day moving average?
          TVRD 20-day moving average is 26.11, which suggests TVRD is a Buy.
            What is TVRD’s 50-day moving average?
            TVRD’s 50-day moving average is 20.03, which suggests TVRD is a Buy.
              What is TVRD’s 200-day moving average?
              TVRD’s 200-day moving average is 14.23, which suggests TVRD is a Buy.
                What is TVRD’s Williams % R (14)?
                TVRD’s Williams % R (14) is -13.00, which suggests TVRD is a Sell.
                  What is TVRD’s CCI (14)?
                  TVRD’s CCI (14) is 250.94, which suggests TVRD is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis